Ipilimumab vs Levothyroxine
Ipilimumab vs Levothyroxine: Overview
This comparison examines the pharmacological differences between Ipilimumab and Levothyroxine.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Levothyroxine: Synthetic thyroid hormone T4 replacement.
Pharmacokinetics
Half-life: Ipilimumab — 14.7 days; Levothyroxine — 6-7 days.
Chemical Properties
Molecular Formula: Levothyroxine — C15H11I4NO4.
Molecular Weight: Levothyroxine — 776.8700 g/mol.
Type: Ipilimumab — Antibody; Levothyroxine — Small molecule.